Reaction

Neuritis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,519 reports · 96 co-occurring drugs

As of the last recalculation, Neuritis appears in 1,519 FAERS reports alongside 96 co-occurring drug terms. The strongest observed disproportionality signal is DUTASTERIDE (PRR 282.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Dutasteride	151	282.4	287.8
Drs. Clotrimazole	174	232.8	236.4
Family Wellness Clotrimazole	174	232.8	236.4
Clotrimazole Topical	174	232.7	236.3
Cefuroxime	165	221.7	225.0
Clotrimazole	174	219.1	222.2
Ciclesonide	156	174.8	176.8
Insulin Glargine-Yfgn	183	130.2	131.3
Cephalexin	177	126.7	127.8
Moxifloxacin	116	122.1	123.1
Moxifloxacin Hydrochloride	141	104.9	105.7
Tamsulosin Hydrochloride	116	84.3	84.7
Sennosides	164	84.2	84.6
Magnesium Oxide	220	84.1	84.5
Candesartan	170	73.4	73.8
Antacid	207	69.0	69.3
Doxazosin Mesylate	162	68.7	69.0
Candesartan Cilexetil	119	67.2	67.5
Doxazosin	125	66.6	66.9
Levofloxacin	231	61.7	62.0
Levofloxacin In 5% Dextrose	231	61.7	62.0
Azithromycin	158	59.9	60.2
Azithromycin Monohydrate	159	58.3	58.5
Umeclidinium Bromide And Vilanterol Trifenatate	66	56.5	56.8
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	153	56.2	56.4
Diltiazem Hydrochloride Extended-Release Tablets	45	55.8	56.0
Mepolizumab	176	54.8	55.0
Budesonide	204	54.6	54.8
Calcium Carbonate	227	54.3	54.5
Diltiazem Hydrochloride	117	50.1	50.3
Azithromycin Dihydrate	185	49.1	49.2
Bisacodyl Suppositories	44	48.0	48.1
Biscodyl	44	47.5	47.7
Liraglutide	152	46.7	46.9
Trimethoprim	39	46.5	46.7
Bisacodyl	46	46.1	46.3
Alendronate Sodium	256	41.6	41.7
Fluticasone Propionate And Salmeterol Xinafoate	151	38.1	38.2
Azathioprine	205	36.7	36.8
Senna Leaf	58	35.8	35.9
Salmeterol Xinafoate	20	32.2	32.3
Albuterol	229	30.6	30.7
Escitalopram Oxalate	147	30.5	30.5
Insulin Aspart	132	29.9	29.9
Fluticasone Furoate And Vilanterol Trifenatate	74	29.6	29.6
Thiamine Hydrochloride	26	29.1	29.2
Mometasone	37	28.3	28.4
Escitslopram	106	26.8	26.8
Montelukast	148	26.7	26.7
Pantoprazole Sodium In 0.9% Sodium Chloride	110	26.1	26.2
Pantoprazole Sodium Injection	110	26.1	26.2
Metformin Hydrochloride Tablets	101	25.8	25.8
Metformin Hydrochloride Extended-Release Tablets	101	25.8	25.8
Metformin Hydrochloride Tablet	101	25.8	25.8
Metformin Hydrochloride	102	25.2	25.3
Rosuvastatin Calcium	47	23.6	23.6
Senna	32	21.2	21.3
Amoxicillin And Clavulanate Potassium	39	20.2	20.2
Sennosides 8.6 Mg Tablets	30	20.0	20.0
Levothyroxine Sodium Anhydrous	131	19.5	19.5
Montelukast Sodium	151	18.8	18.8
Sulfamethoxazole And Trimethoprim	106	18.4	18.5
Tiotropium Bromide	163	18.1	18.2
Alendronate Sodium Tablet	24	18.0	18.0
Escitalopram	163	17.7	17.7
Apixaban	75	16.1	16.1
Hydrochlorothiazide	152	15.8	15.8
Mometasone Furoate	46	15.6	15.6
Fluticasone Furoate	12	13.7	13.7
Albuterol Sulfate	250	13.6	13.6
Insulin Glargine	198	12.5	12.5
Pantoprazole Sodium	124	12.4	12.4
Rifampicin	9	12.3	12.3
Carbamazepine	57	12.1	12.1
Fluticasone Propionate	104	11.7	11.7
Sertraline Hydrochloride	94	11.5	11.5
Amoxicillin	61	11.4	11.4
Fluticasone Propionate Nasal	23	10.5	10.6
Dapsone	8	10.3	10.3
Metformin	227	10.1	10.1
Daspone	7	9.9	9.9
Dapsone Gel, 5%	7	9.9	9.9
Pioglitazone	28	9.0	9.0
Metformin Er 500 Mg	172	8.7	8.7
Metformin Er 750 Mg	172	8.7	8.7
Finasteride	37	8.6	8.6
Bleomycin Sulfate	5	6.7	6.7
Polatuzumab Vedotin	4	5.6	5.6
Dabrafenib	8	5.2	5.2
Diclofenac Potassium, Film Coated	3	4.9	4.9
Diclofenac Potassium Tablets	3	4.9	4.9
Ocrelizumab	21	4.7	4.7
Nivolumab	29	4.2	4.2
Ipilimumab	13	4.2	4.2
Benralizumab	6	4.1	4.1
Tafamidis	3	3.5	3.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.